Nuo Therapeutics Inc (NUOTQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 17 | 9 | 185 | 637 | 250 |
| Receivables | N/A | 10 | 47 | 22 | 255 |
| Inventories | 3 | 10 | 17 | 25 | 34 |
| TOTAL | $24 | $97 | $378 | $867 | $614 |
| Non-Current Assets | |||||
| PPE Net | 15 | 54 | 80 | 106 | 131 |
| Other Non-Current Assets | 0 | 3 | 3 | 3 | 15 |
| TOTAL | $15 | $57 | $84 | $109 | $146 |
| Total Assets | $39 | $154 | $461 | $976 | $760 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 424 | N/A | 345 | 323 | 17 |
| Accounts payable and accrued liabilities | 650 | 634 | 531 | 437 | 481 |
| Accrued Expenses | 250 | 309 | 298 | 297 | 316 |
| TOTAL | $1,323 | $943 | $1,173 | $1,058 | $1,342 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 404 | 0 | 0 | 0 |
| TOTAL | $N/A | $404 | $N/A | $N/A | $N/A |
| Total Liabilities | $1,323 | $1,347 | $1,173 | $1,058 | $1,342 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 23,722 | 23,722 | 23,722 | 23,722 | 23,722 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -23,470 | -23,377 | -22,897 | -22,217 | -22,585 |
| TOTAL | $-1,285 | $-1,192 | $-712 | $-82 | $-582 |
| Total Liabilities And Equity | $39 | $154 | $461 | $976 | $760 |